AU2002258910B2 - Smallpox vaccine - Google Patents

Smallpox vaccine Download PDF

Info

Publication number
AU2002258910B2
AU2002258910B2 AU2002258910A AU2002258910A AU2002258910B2 AU 2002258910 B2 AU2002258910 B2 AU 2002258910B2 AU 2002258910 A AU2002258910 A AU 2002258910A AU 2002258910 A AU2002258910 A AU 2002258910A AU 2002258910 B2 AU2002258910 B2 AU 2002258910B2
Authority
AU
Australia
Prior art keywords
vaccinia virus
strain
atcc deposit
virus
pta
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2002258910A
Other languages
English (en)
Other versions
AU2002258910A1 (en
Inventor
Thomas P. Monath
Richard A. Weltzin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Emergent Product Development Gaithersburg Inc
Original Assignee
Emergent Product Development Gaithersburg Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Emergent Product Development Gaithersburg Inc filed Critical Emergent Product Development Gaithersburg Inc
Publication of AU2002258910A1 publication Critical patent/AU2002258910A1/en
Application granted granted Critical
Publication of AU2002258910B2 publication Critical patent/AU2002258910B2/en
Assigned to SANOFI PASTEUR BIOLOGICS, LLC reassignment SANOFI PASTEUR BIOLOGICS, LLC Request to Amend Deed and Register Assignors: ACAMBIS INC.
Assigned to EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC. reassignment EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC. Request for Assignment Assignors: SANOFI PASTEUR BIOLOGICS, LLC
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/275—Poxviridae, e.g. avipoxvirus
    • A61K39/285—Vaccinia virus or variola virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24161—Methods of inactivation or attenuation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Biotechnology (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU2002258910A 2001-04-23 2002-04-23 Smallpox vaccine Ceased AU2002258910B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/840,751 US6723325B1 (en) 2001-04-23 2001-04-23 Smallpox vaccine
US09/840,751 2001-04-23
PCT/US2002/012616 WO2002085411A1 (en) 2001-04-23 2002-04-23 Smallpox vaccine

Publications (2)

Publication Number Publication Date
AU2002258910A1 AU2002258910A1 (en) 2003-04-17
AU2002258910B2 true AU2002258910B2 (en) 2007-10-25

Family

ID=25283120

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002258910A Ceased AU2002258910B2 (en) 2001-04-23 2002-04-23 Smallpox vaccine

Country Status (19)

Country Link
US (2) US6723325B1 (https=)
EP (1) EP1381389B1 (https=)
JP (1) JP4397591B2 (https=)
KR (1) KR20040063083A (https=)
CN (1) CN1527722A (https=)
AU (1) AU2002258910B2 (https=)
BR (1) BR0209145A (https=)
CA (1) CA2444747C (https=)
CZ (1) CZ305819B6 (https=)
EA (1) EA007656B1 (https=)
ES (1) ES2546612T3 (https=)
HU (1) HU228401B1 (https=)
IL (2) IL158549A0 (https=)
MA (1) MA26270A1 (https=)
MX (1) MXPA03009711A (https=)
NZ (1) NZ529265A (https=)
PL (1) PL212117B1 (https=)
WO (1) WO2002085411A1 (https=)
ZA (1) ZA200309084B (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7645456B2 (en) * 2001-04-23 2010-01-12 Sanofi Pasteur Biologics Co. Vaccinia virus strains
US6723325B1 (en) * 2001-04-23 2004-04-20 Acambis, Inc. Smallpox vaccine
US20090269365A1 (en) * 2005-04-20 2009-10-29 University Of Washington Immunogenic vaccinia peptides and methods of using same
MX2009004862A (es) 2006-11-07 2009-07-17 Sanofi Pasteur Biologics Co Estabilizacion de vacunas por liofilizacion.
KR100859345B1 (ko) * 2006-12-12 2008-09-19 씨제이제일제당 (주) 세포배양에 의해 두창 백신을 생산하는 방법 및 그에 의해생산된 두창 백신
ES2733211T3 (es) * 2011-04-15 2019-11-28 Genelux Corp Cepas clonales de virus vaccinia atenuados y métodos de uso de las mismas
RU2496149C1 (ru) * 2012-06-19 2013-10-20 Федеральное бюджетное учреждение науки "Государственный научный центр вирусологии и биотехнологии "Вектор" (ФБУН ГНЦ ВБ "Вектор") Способ оценки противооспенной активности лечебно-профилактических препаратов
JP2019535311A (ja) 2016-11-02 2019-12-12 デイビッド エバンス， 合成キメラポックスウイルス
EP3788142A4 (en) 2018-05-02 2022-04-27 Tonix Pharma Holdings Limited SYNTHETIC CHIMERIC VACCINE VIRUS
US11505782B2 (en) 2018-06-04 2022-11-22 Calidi Biotherapeutics, Inc. Cell-based vehicles for potentiation of viral therapy
CA3116192C (en) 2018-11-06 2025-09-23 Calidi Biotherapeutics (Nevada), Inc. IMPROVED SYSTEMS FOR CELL-MEDIATED ONCOLYTIC VIRAL THERAPY
WO2025184411A1 (en) 2024-02-27 2025-09-04 Calidi Biotherapeutics (Nevada), Inc. Serum-resistant eev viruses and uses thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5656465A (en) * 1994-05-04 1997-08-12 Therion Biologics Corporation Methods of in vivo gene delivery

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4315914A (en) * 1980-04-04 1982-02-16 Seiji Arakawa Pharmaceutical compositions useful as cellular immunopotentiator and antitumor agent and process for production thereof
JPS60202827A (ja) 1984-03-28 1985-10-14 Chibaken 弱毒痘そうワクチン株
US5614193A (en) * 1991-11-14 1997-03-25 The United States Of America As Represented By The Secretary Of The Army Hantavirus vaccine
US6723325B1 (en) 2001-04-23 2004-04-20 Acambis, Inc. Smallpox vaccine

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5656465A (en) * 1994-05-04 1997-08-12 Therion Biologics Corporation Methods of in vivo gene delivery

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Kutinova L. et al. (1995) vaccine Vol. 13 No. 5 pages 487-493 *
Monath T.P. et al. (2004) International Journal of Infectious Diseases. Vol 8S2 pages S31-S44. *

Also Published As

Publication number Publication date
US7115270B2 (en) 2006-10-03
JP4397591B2 (ja) 2010-01-13
EP1381389A1 (en) 2004-01-21
HUP0303878A3 (en) 2010-01-28
ES2546612T3 (es) 2015-09-25
KR20040063083A (ko) 2004-07-12
WO2002085411A1 (en) 2002-10-31
MXPA03009711A (es) 2005-03-07
US6723325B1 (en) 2004-04-20
PL373958A1 (en) 2005-09-19
EP1381389B1 (en) 2015-08-26
CA2444747A1 (en) 2002-10-31
US20060153873A1 (en) 2006-07-13
CZ20033184A3 (cs) 2004-04-14
ZA200309084B (en) 2005-01-26
HU228401B1 (en) 2013-03-28
CA2444747C (en) 2018-04-17
PL212117B1 (pl) 2012-08-31
NZ529265A (en) 2006-04-28
HK1062804A1 (zh) 2004-11-26
EA007656B1 (ru) 2006-12-29
EA200301151A1 (ru) 2004-10-28
IL158549A (en) 2009-07-20
MA26270A1 (fr) 2004-09-01
BR0209145A (pt) 2005-04-19
IL158549A0 (en) 2004-05-12
HUP0303878A2 (hu) 2004-03-01
CN1527722A (zh) 2004-09-08
EP1381389A4 (en) 2004-07-28
JP2005503126A (ja) 2005-02-03
CZ305819B6 (cs) 2016-03-30

Similar Documents

Publication Publication Date Title
US20090324548A1 (en) Vaccinia Virus Strains
AU2003239805B2 (en) Modified vaccinia virus ankara for the vaccination of neonates
Pratt et al. Genetically engineered, live attenuated vaccines for Venezuelan equine encephalitis: testing in animal models
AU2002258910B2 (en) Smallpox vaccine
JP5988463B2 (ja) Ｍｖａによる病原体からの即時保護
AU2002258910A1 (en) Smallpox vaccine
Kaplan Vaccinia virus: a suitable vehicle for recombinant vaccines?
HK1062804B (en) Smallpox vaccine
US20250213672A1 (en) Live attenuated junin virus and related compositions and methods
Melnick Poliomyelitis vaccination: what are the options?
Cohen et al. Improved Smallpox Vaccines

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
HB Alteration of name in register

Owner name: SANOFI PASTEUR BIOLOGICS, LLC

Free format text: FORMER NAME(S): ACAMBIS INC.

PC Assignment registered

Owner name: EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC.

Free format text: FORMER OWNER(S): SANOFI PASTEUR BIOLOGICS, LLC

MK14 Patent ceased section 143(a) (annual fees not paid) or expired